Ordering from outside the Americas?Switch to the EU store
We don't ship to your country yet. We ship across Europe and the Americas. You can keep browsing.

Peptency Academy · Testing

How a peptide patch is tested: permeation, content and purity

How is a peptide patch tested for permeation, content and purity?

The EMA guideline on transdermal patches, adopted on 23 October 2014, discusses in vitro drug release, adhesion and skin permeation testing. Source sentenceIn particular, in vitro performance testing with respect to drug release, adhesion and skin permeation is discussed1 EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014 A 2025 white paper from international stakeholders lists more than twenty critical quality attributes for a microneedle product form. Source sentenceAbstract: more than twenty potential critical quality attributes (CQAs) are identified for the product form.2 J Control Release 2025

Version 1Edited 12 sources

Known, not known, contested

Known

  • Fracture force per microneedle is a standard mechanical readout: 3.47 N in one semaglutide patch and 0.37 N in another. Source sentencerobust mechanical strength (3.47 N/needle; fracture force)3 AAPS PharmSciTech 20264 Int J Nanomedicine 2025
  • Skin barrier recovery after patch removal is followed by transepidermal water loss: 10 to 12 hours in the exenatide hyaluronate study. Source sentencetransepidermal water loss (TEWL) determinations showed that skin's barrier properties disrupted by MNs recovered within 10-12 h5 Pharm Res 2014

Not known

Contested

Nothing listed yet.

A test sequence for a microneedle patch

  1. Mechanical strength comes first: fracture force per microneedle, measured by axial compression. Source sentenceresisted axial compression7 Int J Pharm 20263 AAPS PharmSciTech 2026
  2. Insertion is checked next, in layered Parafilm M film or in porcine skin. Source sentenceexcellent Parafilm M insertion (> 50% at 450 μm depth) ... ex-vivo porcine skin insertion3 AAPS PharmSciTech 2026
  3. Release is measured in a dissolution bath or a Franz cell, and skin barrier recovery is followed by transepidermal water loss. Source sentenceThe resulting system was placed in a dissolution bath and the release of model molecules was evaluated.8 Int J Pharm 20165 Pharm Res 2014
  4. Permeation goes through excised skin in a diffusion cell with a receptor solution that holds sink conditions. Source sentenceThe receptor solution should provide solubility sink conditions throughout the experiment1 EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014
  5. Content per patch comes from extracting the peptide from the microneedles and assaying it. Source sentenceAn accurate and reliable method was established to determine the needle drug loading proportion in sCT-DMNAs.9 AAPS PharmSciTech 2020
  6. Purity and identity of that extract are then read like any other peptide sample: HPLC area percent for purity and mass spectrometry for identity. Source sentenceThe peptide purity was quantified through normalization by calculating the area (UV) of the most abundant peak as a percentage of total peak areas.10 J Pharm Anal 2015

What the EMA guideline asks of a transdermal patch

What microneedle patches add

  • Because biological skin varies, one group proposed Parafilm M layers as a test membrane. A 196 microneedle array with 600 µm microneedles released between 40 and 180 µg of cargo in 6 hours. Source sentenceDissolving MN arrays containing 196 needles (600 μm needle height) were inserted into a single layer of PF ... releasing between 40 and 180 μg of their cargos after 6h.8 Int J Pharm 2016
  • In that work the Parafilm pouch and a Franz cell gave comparable release curves. Source sentencethe use of PF membrane was tested either in the hermetic "pouch" and using Franz Cell methodology yielding comparable release curves8 Int J Pharm 2016
  • It flags delivered amount and puncture performance as attributes that will need bespoke test methods, and dissolution as a method that needs major adaptation. Source sentenceAbstract, final sentences: the most pertinent attributes will likely require bespoke test methods or major adaptions to established compendial test methods (dissolution).2 J Control Release 2025
  • Variability of the amount delivered into skin was under 6.8 percent for the pure tip liraglutide patch, from 0.93 ± 0.04 mg delivered. Source sentenceAbstract: the patch could deliver up to 0.93 ± 0.04 mg of liraglutide into skin with a variability of less than 6.8%.11 Drug Deliv Transl Res 2025

What a patch certificate line could look like

  • Peptide content per patch
    Method
    Extraction from the microneedle array, then HPLC assay
    Reports
    Mass of peptide per patch
  • Purity of the extract
    Method
    HPLC, UV chromatography, area normalisation
    Reports
    Main peak area percent
  • Identity of the extract
    Method
    LC-MS
    Reports
    Observed mass against theoretical mass
  • Fracture force
    Method
    Axial compression of the microneedles
    Reports
    Force per microneedle
  • Insertion
    Method
    Multi-layer Parafilm M film
    Reports
    Percent of layers pierced at each depth
  • In vitro release
    Method
    Dissolution bath or Franz cell
    Reports
    Cumulative amount released over time
Layout only, not a Peptency lot or product. The lines a patch certificate would carry beside the usual purity and identity lines.

Terms in patch testing

Franz cell
A Franz cell is a two chamber diffusion cell. Skin sits between a donor chamber that holds the patch and a receptor chamber that is sampled over time. Source sentenceThe most common diffusion cells are Franz-type (static) cells, which consist of two chambers that can be side-by-side or1 EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014
Sink conditions
Sink conditions: the receptor solution can dissolve the active so well that the receptor never limits permeation. Source sentenceAn acceptable sink ... the permeation of the active substance is not limited by the receptor medium1 EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014
Critical quality attribute
Critical quality attribute: a property of the finished product that has to stay in a defined range for quality to hold. Source sentenceAbstract: more than twenty potential critical quality attributes (CQAs) are identified for the product form.2 J Control Release 2025
Transepidermal water loss
Transepidermal water loss: a measure of skin barrier function, used to follow how fast skin recovers after microneedles. Source sentencetransepidermal water loss (TEWL) determinations showed that skin's barrier properties disrupted by MNs recovered within 10-12 h5 Pharm Res 2014
Relative bioavailability
Relative bioavailability compares exposure from a patch with exposure from a reference route, for example 69.8 percent in rats for the liraglutide patch. Source sentenceachieved relative bioavailability of 69.8% and 46.3% compared to S.C. injection in rats and minipigs, respectively11 Drug Deliv Transl Res 2025

Purity is not content, for a patch too

  • HPLC purity is the area of the main peak as a percentage of the total peak area in a UV chromatogram of the sample, so it describes the extract and not the amount of peptide. Source sentenceThe peptide purity was quantified through normalization by calculating the area (UV) of the most abundant peak as a percentage of total peak areas.10 J Pharm Anal 2015
  • An accurate extraction and assay method for the loading in the microneedle tips was established for a salmon calcitonin array. Source sentenceAn accurate and reliable method was established to determine the needle drug loading proportion in sCT-DMNAs.9 AAPS PharmSciTech 2020

What is a Franz cell?

A Franz cell is a two chamber diffusion cell. Skin sits between a donor chamber that holds the patch and a receptor chamber that is sampled over time. Source sentenceThe most common diffusion cells are Franz-type (static) cells, which consist of two chambers that can be side-by-side or1 EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014

Why does Parafilm appear in microneedle tests?

Parafilm M stands in for skin in routine microneedle tests, because biological tissue varies from sample to sample and is a poor fit for quality control. Source sentenceThe use of biological tissues in the in vitro assessments ... presents some fundamental difficulties, in part due to inherent variability of the biological tissues employed.8 Int J Pharm 2016

What is the difference between loading and delivered amount?

Loading is the peptide in the patch; delivered amount is what leaves the patch into the skin. In one semaglutide study the two were 29 µg and 18 µg, a delivered fraction of 63 percent. Source sentence29 ± 2 μg semaglutide per patch, with an apparent delivered amount of 18 ± 2 μg (63 ± 3%; n = 3)7 Int J Pharm 2026

What does a peptide patch certificate of analysis report?

A certificate for a patch is most useful when it reports peptide content per patch, purity and identity of the extract, and the mechanical and release results. Source sentenceLab results page: HPLC purity, LC-MS identity, net content.12 Peptency lab results and certificate of analysis page10 J Pharm Anal 20152 J Control Release 2025

Published examples with IDs

  1. Analytical only (no biological model)International journal of pharmaceutics 2016

    Release of model cargos from 196 microneedle arrays over 6 hours

    Design
    Parafilm M pouch release test compared with Franz cell methodology for dissolving arrays
    Population or model
    Parafilm M membrane
    Molecule
    Model cargos not established

    PubMed 26621687DOI

  2. Analytical only (no biological model)Journal of controlled release : official journal of the Controlled Release Society 2025

    Classification, nomenclature and more than twenty critical quality attributes

    Design
    White paper by international stakeholders on regulatory science of microneedle product forms
    Molecule
    Microneedle product forms not established

    PubMed 39603537DOI

  3. In vitro or ex vivoAAPS PharmSciTech 2026

    Fracture force, Parafilm insertion depth, release over 12 hours and ex vivo porcine skin insertion

    Design
    Formulation and characterisation of dissolving microneedles with hyaluronic acid, PETOX and L-arginine
    Population or model
    Parafilm M, porcine skin ex vivo
    Molecule
    Semaglutide exact

    PubMed 42393458DOI

  4. RodentInternational journal of pharmaceutics 2026

    Loading per patch, apparent delivered amount, release within 30 minutes and skin barrier recovery

    Design
    Polyvinyl alcohol dissolving microneedles made by vacuum assisted molding, tested in rat skin
    Population or model
    Rats
    Molecule
    Semaglutide exact
    n
    3
    Comparator
    Unloaded microneedle controls

    PubMed 42906796DOI

  5. RodentDrug delivery and translational research 2025

    Loading up to 2.21 mg per 0.9 cm², delivered amount, relative bioavailability and local skin response

    Design
    Dissolving microneedle patch with pure drug tips, pharmacokinetics in rats and minipigs
    Population or model
    Rats and minipigs
    Molecule
    Liraglutide related form

    PubMed 38619705DOI

Sources

  1. 1EMA, Guideline on quality of transdermal patches, EMA/CHMP/QWP/608924/2014 accessed 11 Nov 2026
  2. 2J Control Release 2025 accessed 11 Nov 2026
  3. 3AAPS PharmSciTech 2026 accessed 11 Nov 2026
  4. 4Int J Nanomedicine 2025 accessed 11 Nov 2026
  5. 5Pharm Res 2014 accessed 11 Nov 2026
  6. 6PubMed search for transdermal patch without microneedles, 11 November 2026 accessed 11 Nov 2026
  7. 7Int J Pharm 2026 accessed 11 Nov 2026
  8. 8Int J Pharm 2016 accessed 11 Nov 2026
  9. 9AAPS PharmSciTech 2020 accessed 11 Nov 2026
  10. 10J Pharm Anal 2015 accessed 11 Nov 2026
  11. 11Drug Deliv Transl Res 2025 accessed 11 Nov 2026
  12. 12Peptency lab results and certificate of analysis page accessed 11 Nov 2026

About this page

Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.

Reviewed by the Peptency editorial process. Version 1, edited 11 November 2026, 12 sources.

Cite this page: Peptency Academy. How a peptide patch is tested: permeation, content and purity. Version 1./us/academy/testing/how-a-peptide-patch-is-tested/